Inhibition of TGF-β Enhances the In Vivo Antitumor Efficacy of EGF Receptor–Targeted Therapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Inhibition of TGF-β Enhances the In Vivo Antitumor Efficacy of EGF Receptor–Targeted Therapy

Published:2012-08-27 Issue:11 Volume:11 Page:2429-2439
ISSN:1535-7163
Container-title:Molecular Cancer Therapeutics
language:en
Short-container-title:Mol Cancer Ther

Author:

Bedi Atul,Chang Xiaofei,Noonan Kimberly,Pham Vui,Bedi Rishi,Fertig Elana J.,Considine Michael,Califano Joseph A.,Borrello Ivan,Chung Christine H.,Sidransky David,Ravi Rajani

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 70 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advancements in TGF-β Targeting Therapies for Head and Neck Squamous Cell Carcinoma;Cancers;2024-08-31

2. Regulatory crosstalk between TGF-β signaling and miRNAs: a head and neck cancer perspective;The Nucleus;2024-07-13

3. Radiomics-based model for prediction of TGF-β1 expression in head and neck squamous cell carcinoma;American Journal of Nuclear Medicine and Molecular Imaging;2024

4. A Phase II Exploratory Study to Identify Biomarkers Predictive of Clinical Response to Regorafenib in Patients with Metastatic Colorectal Cancer Who Have Failed First-Line Therapy;International Journal of Molecular Sciences;2023-12-19

5. Advantages of the Combinatorial Molecular Targeted Therapy of Head and Neck Cancer—A Step before Anakoinosis-Based Personalized Treatment;Cancers;2023-08-24

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP